FDA Briefing Document NDA 22529

First Page		Document Content
G protein coupled receptors Lorcaserin 5-HT2A receptor 5-HT2C receptor Agonist 5-HT2B receptor Ligand Anti-obesity medication Serotonin Biology Cell signaling Cell biology		FDA Briefing Document NDA 22529 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 3,60 MB Share Document on Facebook

	Key-Obs bibliography Mouton-Liger F, Sahún I, Collin T, Lopes Pereira P, Masini D, Thomas S, Paly E, Luilier S, Même S, Jouhault Q, Bennaï S, Beloeil JC, Bizot JC, Hérault Y, Dierssen M, Créau NDevelopmenta DocID: 1pAv0 - View Document
	Microsoft Word - setor_03_Psychopharmacology.docx DocID: 1gcAN - View Document
	5-hydroxytryptamine has an endothelium-derived hyperpolarizing factor-like effect on coronary flow in isolated rat hearts DocID: 1fOBf - View Document
	Microsoft Word - Session_01-Cellular and Molecular Pharmacology.doc DocID: 1fDjk - View Document
	Neurochem Res DOIs11064OVERVIEW On the Discovery and Development of Pimavanserin: A Novel DocID: 1auRu - View Document